Ronald Kirk Huntsman, Chief Executive Officer, 10% Owner at Vivos Therapeutics, Inc. (VVOS), bought 12,000 shares at $1.83 ($24K) on 2022-06-01, disclosed to the SEC on 2022-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.03 | 8,000 | $16K | 68.9% |
| 2 | $1.83 | 4,000 | $7K | 31.1% |
| Total | $1.96 avg | 12,000 | $24K | 100% |
| Filing → |
| VVOS | BUY | 2023-06-15 | $5K | — | Filing → |
| VVOS | BUY | 2022-12-28 | $10K | — | Filing → |
| VVOS | BUY | 2021-09-22 | $22K | — | Filing → |